Respiratory chain gene mutations associated with global phylogenetic clustering of drug-resistant Mycobacterium tuberculosis revealed by whole-genome sequencing - Report - MDSpire

Respiratory chain gene mutations associated with global phylogenetic clustering of drug-resistant Mycobacterium tuberculosis revealed by whole-genome sequencing

  • By

  • Qiang Ji

  • Yawei Hou

  • Yameng Li

  • May 20, 2026

  • 0 min

Share

Gene Mutations in the Respiratory Chain Linked to Drug-Resistant Mycobacterium tuberculosis

Overview

This study identifies specific gene mutations in the respiratory chain of Mycobacterium tuberculosis that are associated with multidrug-resistant (MDR) isolates. Whole-genome sequencing revealed significant single nucleotide polymorphisms (SNPs) linked to the phylogenetic clustering and development of MDR strains.

Background

Multidrug-resistant tuberculosis (MDR-TB) poses a significant challenge to global health, with rising incidence rates complicating treatment efforts. Understanding the genetic basis of drug resistance, particularly through mutations in respiratory chain genes, is crucial for developing effective therapeutic strategies. This study leverages whole-genome sequencing to explore the relationship between these mutations and MDR-TB transmission.

Data Highlights

Isolate TypeCountPercentage
MDR Isolates405130.09%
Single-Drug Resistance (SDR)10447.76%

Key Findings

  • 13402 isolates of Mycobacterium tuberculosis were analyzed.
  • 30.09% of isolates were identified as multidrug-resistant (MDR).
  • Significant SNPs associated with MDR included atpH A428G, cydA C942A, and qcrA G181C.
  • Mutations in respiratory chain genes may influence drug metabolism, reducing treatment efficacy.
  • The study highlights the importance of whole-genome sequencing in understanding MDR-TB transmission dynamics.

Clinical Implications

The identification of specific SNPs in respiratory chain genes provides insights that could inform the development of targeted therapies for MDR-TB. Clinicians should consider these genetic factors when designing treatment regimens and monitoring resistance patterns.

Conclusion

This research underscores the critical role of respiratory chain gene mutations in the phylogenetic clustering and development of MDR Mycobacterium tuberculosis, offering new avenues for therapeutic intervention.

Related Resources & Content

  1. The Journal of Infectious Diseases, 2023 -- Genomic Analysis of Global Mycobacterium abscessus Isolates Reveals Ongoing Evolution of Drug Resistance–Associated Genes
  2. Infection, 2024 -- Next-Generation Sequencing as an Effective Method for Diagnosing Mycobacterium tuberculosis and Assessing Drug Resistance
  3. Open Forum Infectious Diseases, 2024 -- Extensive Endemic Transmission of Multidrug-Resistant Mycobacterium tuberculosis in Bhutan: A Retrospective Genomic-Epidemiological Study
  4. The Journal of Infectious Diseases, 2023 -- Engineered Mycobacteriophage TM4::GeNL Rapidly Determines Bedaquiline, Pretomanid, Linezolid, Rifampicin, and Clofazimine Sensitivity in Mycobacterium tuberculosis Clinical Isolates
  5. WHO, 2024 -- WHO issues rapid communication on key updates to the treatment of drug-resistant tuberculosis
  6. TB PRACTECAL | MSF UK, 2024 -- TB PRACTECAL
  7. WHO, 2023 -- Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, 2nd ed
  8. WHO issues rapid communication on key updates to the treatment of drug-resistant tuberculosis
  9. TB PRACTECAL | MSF UK
  10. Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, 2nd ed

Original Source(s)

Related Content